FDA approves an antibody-drug conjugate for people with HER2-ultralow breast cancer, and historic redlining practices have a lingering impact on cancer outcomes.

by Thomas Celona

Studies underscore the strength of exercise recommendations, and new radiation therapy technique poised to make a flash.

by Marci A. Landsmann

Cancer incidence on the rise in younger women, and a new report issued on alcohol and health.

by Kevin McLaughlin

Getting more calcium could lower risk for colorectal cancer, and research provides new insight into which BRCA2 mutations can lead to cancer.

by Thomas Celona

New year brings debate about dangers of alcohol, and insurance denials continue to delay care.

by Marci A. Landsmann

Active surveillance of DCIS patients may be an alternative to treatment, and guidelines add self-test for HPV.

by Kevin McLaughlin

HPV vaccine credited for decrease in cervical cancer deaths among young women, and new technology extends survival in locally advanced pancreatic cancer.

by Thomas Celona

Pancreatic cancer surge in younger people has not led to a rise in deaths, and researchers will study long-term survivors to better understand cancer responses.

by Eric Fitzsimmons

Complications can affect men years after prostate cancer treatment, and many people eligible for lung cancer screening do not get it.

by Kevin McLaughlin

Early initiation of palliative care leads to fewer hospital admissions, and surgery that removes fewer lymph nodes is effective for localized muscle-invasive bladder cancer.

by Marci A. Landsmann